Addex Therapeutics (ADXN) vs Dermata Therapeutics (DRMA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Addex Therapeutics is the larger company by market cap ($5.6 million vs $5.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ADXN | DRMA |
|---|---|---|
| Share price | $3.18 | $1.07 |
| Market cap | $5.57M | $5.30M |
| 1-day change | +6.81% | -4.46% |
| EPS (TTM) | $-7.56 | $-4.39 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.97 | $4.66 |
| 52-week low | $2.56 | $0.951 |
| Distance from 52-week high | -73.43% | -77.04% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +273.83% |
| Average volume | 138.01K | 706.43K |
| Shares outstanding | 1.75M | 4.96M |
| Employees | 3 | 9 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Addex Therapeutics
ADXN stock →Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes.
Healthcare · Biotechnology · 3 employees
About Dermata Therapeutics
DRMA stock →Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States.
Healthcare · Biotechnology · 9 employees
ADXN vs DRMA FAQ
Which is bigger, Addex Therapeutics or Dermata Therapeutics?
Addex Therapeutics (ADXN) is larger, with a market capitalization of $5.57M compared with $5.30M for Dermata Therapeutics (DRMA).
Are Addex Therapeutics and Dermata Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.